EMAIL THIS PAGE TO A FRIEND

Laboratory investigation; a journal of technical methods and pathology

Vitronectin-binding PAI-1 protects against the development of cardiac fibrosis through interaction with fibroblasts.


PMID 24687120

Abstract

Plasminogen activator inhibitor-1 (PAI-1) promotes or abates fibrotic processes occurring in different organs. Binding of PAI-1 to vitronectin, an extracellular matrix component, may inhibit vitronectin-integrin complex-mediated cellular responses in pathophysiological conditions. To investigate the importance of plasmin suppression vs vitronectin-binding pathways of PAI-1 in cardiac fibrosis, we studied uninephrectomized mice fed a high salt diet and infused with angiotensin II (Ang II) together with different PAI-1 variants, including PAI-1AK (AK) that inhibits plasminogen activators but does not bind vitronectin, PAI-1RR (RR) that binds vitronectin but does not have protease inhibitory effects or control PAI-1 (CPAI), the control mutant that has similar molecular backbone and half-life as AK and RR while retaining all functions of native PAI-1. Compared with RR and CPAI, non-vitronectin-binding AK significantly increased expression of cardiac fibroblast marker, periostin (Ang+AK 8.40±3.55 vs Ang+RR 2.23±0.44 and Ang+CPAI 2.33±0.12% positive area, both P<0.05) and cardiac fibrosis (Ang+AK 1.79±0.26% vs Ang+RR 0.91±0.18% and Ang+CPAI 0.81±0.12% fibrotic area, both P<0.05), as well as Col1 mRNA (Ang+AK 12.81±1.84 vs Ang+RR 4.04±1.06 and Ang+CPAI 5.23±1.21 fold increase, both P<0.05). To elucidate mechanisms underlying the protective effects of vitronectin-binding PAI-1 against fibrosis, fibroblasts from normal adult human ventricles were stimulated with Ang and different PAI-1 variants. Protease inhibitory AK and CPAI increased supernatant fibronectin, while decreasing plasminogen activator/plasmin activities and matrix metalloproteinase. RR and CPAI variants significantly reduced fibroblast expression of integrin β3, vitronectin level in the supernatant and fibroblast adhesion to vitronectin compared with the non-vitronectin-binding AK. Further, RR and CPAI preserved apoptotic, decreased anti-apoptotic and proliferative activities in fibroblasts. Thus, PAI-1 promotes or protects against development of cardiac fibrosis differentially through the protease inhibitory pathway or through its binding to vitronectin.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

B3428 Anti-Bax antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
SAB3500343
Anti-Bax antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
HPA027878
Anti-BAX antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4502549
Anti-BAX antibody produced in rabbit, affinity isolated antibody
B8429
Anti-Bax antibody, Mouse monoclonal, clone 6A7, purified from hybridoma cell culture
B8554
Anti-Bax antibody, Mouse monoclonal, clone 2D2, purified from hybridoma cell culture
M9570 Anti-Matrix Metalloproteinase-9 antibody produced in goat, affinity isolated antibody
HPA001238
Anti-MMP9 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
AV33090
Anti-MMP9 antibody produced in rabbit, IgG fraction of antiserum
SAB2101602
Anti-NKX3-1 (ab1) antibody produced in rabbit, affinity isolated antibody
SAB2101603
Anti-NKX3-1 (ab2) antibody produced in rabbit, affinity isolated antibody
SAB1412056
ANTI-NKX3-1 antibody produced in mouse, clone 3C1, purified immunoglobulin, buffered aqueous solution
SAB1406589
Anti-VTN antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB1411393
Anti-VTN antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
B9054 Monoclonal Anti-Bax antibody produced in mouse, 2 mg/mL, clone 5B7, purified immunoglobulin, buffered aqueous solution
WH0000581M1
Monoclonal Anti-BAX antibody produced in mouse, clone 1F5-1B7, purified immunoglobulin, buffered aqueous solution
AMAB90805
Monoclonal Anti-MMP9 antibody produced in mouse, Prestige Antibodies® Powered by Atlas Antibodies, clone CL0539, purified immunoglobulin, buffered aqueous glycerol solution
AMAB90804
Monoclonal Anti-MMP9 antibody produced in mouse, Prestige Antibodies® Powered by Atlas Antibodies, clone CL0538, purified immunoglobulin, buffered aqueous glycerol solution
SAB5300247
Monoclonal Anti-MMP9 antibody produced in mouse, clone 5G3, ascites fluid
SAB5300248
Monoclonal Anti-MMP9 antibody produced in mouse, clone 5C3, ascites fluid
AMAB90806
Monoclonal Anti-MMP9 antibody produced in mouse, Prestige Antibodies® Powered by Atlas Antibodies, clone CL0542, purified immunoglobulin, buffered aqueous glycerol solution
SAB1402274
Monoclonal Anti-MMP9 antibody produced in mouse, clone 2H4, purified immunoglobulin, buffered aqueous solution
WH0004824M2
Monoclonal Anti-NKX3-1 antibody produced in mouse, clone 1C7, purified immunoglobulin, buffered aqueous solution
SAB1404130
Monoclonal Anti-NKX3-1 antibody produced in mouse, clone 3H6, purified immunoglobulin, buffered aqueous solution
SAB5300411
Monoclonal Anti-NKX3-1 antibody produced in mouse, clone 4H4, ascites fluid
V7881 Monoclonal Anti-Vitronectin antibody produced in mouse, clone VIT-2, ascites fluid